Nomad Foods Earnings Call Transcripts
Fiscal Year 2025
-
2026 is expected to be a transition year with negative net sales due to pricing negotiations and fish cost inflation, but management remains confident in long-term growth, planning share purchases and continued investment in innovation and retail execution.
-
Organic sales and EBITDA declined year-over-year, with gross margin pressured by inflation. 2026 is set as a transition year with expected revenue and profit declines, but leadership is confident in long-term value creation and has prioritized share repurchases and cost savings.
-
Medium-term efficiency and EBITDA growth targets remain intact, with most pricing actions deferred to Q1 2026 and a focus on cost savings and product renovation. Q4 guidance is reiterated at the low end, and capital allocation will prioritize share buybacks amid increased liquidity.
-
Q3 saw a 2.2% revenue decline and 1.6% organic sales drop, mainly due to U.K. weakness and margin pressure from inflation and delayed price hikes. Leadership transition is underway, with new CEO-elect and efficiency initiatives set to drive future growth.
-
The company outlined its leadership in European frozen food, recent challenges, and a renewed focus on innovation and efficiency. New medium-term targets include 1–3% EBITDA CAGR and 15% higher free cash flow, supported by a €200 million productivity program and reinvestment in brands and product quality.
-
Guidance was revised lower due to ERP and inventory issues, with weather and inflation further impacting results. Market share gains and cost savings were achieved, while innovation and portfolio diversification are expected to drive future growth.
-
Organic sales declined 1.1% in Q2 2025 due to severe weather impacts, with adjusted EBITDA down 7% and EPS down 9% year-on-year. Full-year guidance was lowered, but market share gains and strong innovation platforms support a positive long-term outlook.
-
The conference highlighted a focused strategy on frozen food, emphasizing health, taste, and value, with strong market share and consistent growth. Innovation, renovation, and disciplined capital deployment drive future opportunities, while private label competition remains a key focus.
-
Net revenues fell 3% in Q1 2025, with organic sales down 3.6% and gross margin up 90 bps. Full-year guidance was lowered due to broad-based retail destocking and higher input costs, but growth is expected to resume in Q2, supported by innovation and strong category fundamentals.
-
Frozen food in Europe is set for continued growth, with strong market share gains, increased investment in innovation, and a focus on health and sustainability. Financial guidance for 2025 projects steady revenue, EBITDA, and EPS growth, supported by robust cash flow and shareholder returns.
Fiscal Year 2024
-
Delivered strong Q4 and full-year results with robust volume growth, margin expansion, and increased shareholder returns. Guidance for 2025 anticipates continued organic growth, higher EPS, and a dividend increase, supported by ongoing innovation and productivity gains.
-
The session highlighted consistent growth, resilience, and leadership in healthy frozen foods, with a focus on innovation, productivity, and targeted investment. ERP challenges are being managed, and future growth is expected from category leadership, margin expansion, and disciplined M&A.
-
Delivered strong Q3 results with record gross margin and double-digit profit growth, despite ERP-related headwinds. Full-year sales and profit guidance were modestly lowered, but momentum in market share and innovation remains robust heading into 2025.
-
The company reinforced its leadership in European frozen food, focusing on health, sustainability, and innovation. Financial guidance for 2024 targets 3-4% revenue growth and strong cash flow, with operational improvements and disciplined capital allocation supporting long-term value creation.
-
Second quarter saw a return to positive volume growth and robust margin expansion, driven by supply chain productivity and premium innovation. Full-year guidance was reiterated, with accelerating momentum expected in H2 and continued strong capital returns to shareholders.